Peptide Hub Australia Vendor Review

Australian Research Peptides Review Australia

Australian Research Peptides is a new Sydney-based Australian research peptide supplier with locally held stock, transparent public pricing and a growing library of supplier-provided Janoshik laboratory reports. The business only began trading in July 2026, so its independent reputation is still developing. Peptide Hub has now also completed a first-hand package audit, with a standard-post order delivered from New South Wales to Queensland in three days.

Peptide Hub Score 60 / 100

Peptide Hub Rating 6.0 / 10

Product Range 25+ products / multiple strengths

Community Reputation Still developing

Testing Supplier-provided Janoshik reports

Pricing Generally above market

Payment PayID & bank transfer

Shipping Sydney dispatch observed

60 OUT OF 100

Peptide Hub verdict: Australian Research Peptides has made a transparent and professional start, but it is still a very new vendor. Supplier-provided Janoshik documentation, responsive communication and a successful package audit are positives. The lack of vendor-commissioned testing, limited independent customer history and comparatively high pricing currently hold the score back.

The strongest part of ARP’s early approach is its willingness to provide information rather than overstate what it has. The company openly confirmed to Peptide Hub that its current Janoshik certificates come from its upstream supplier rather than testing commissioned by Australian Research Peptides itself. That distinction matters and is reflected in our score.

Australian stock Public COA library Package audit completed Transparent communication New vendor Supplier-provided testing Above-market pricing overall

Australian Research Peptides at a Glance

Australian Research Peptides began trading on 12 July 2026. The company told Peptide Hub that it did not operate under another business structure before this date.

Stock is physically held in Australia and orders are dispatched from Sydney. ARP says it currently works with one primary Chinese supplier/manufacturer rather than importing individual customer orders after purchase.

Australian-held stock ARP confirmed that its retail inventory is physically held in Australia and dispatched domestically from Sydney.

25+ research products The current pricing data covers a respectable range of compounds, with multiple strengths available for a number of products.

Public COA library ARP publishes supplier-provided Janoshik reports publicly rather than simply displaying purity percentages without the underlying documents.

What stands out: ARP has been unusually direct with Peptide Hub about where its testing comes from. When questioned about duplicated Janoshik task numbers appearing elsewhere in the Australian market, the business explained that the reports come from its upstream supplier and may therefore also appear with other vendors sourcing the same batches.

Our Ranking Framework

Australian Research Peptides Score: 60/100

Peptide Hub scores vendors across six categories. ARP performs well for website transparency and its first-hand customer experience, but its short trading history and current testing model prevent a higher initial rating.

Category	Score	Assessment
Testing & Transparency	19 / 30	ARP publicly provides supplier-sourced Janoshik certificates and has been transparent with Peptide Hub about their origin. However, the tests were not commissioned by ARP, the business does not possess the unredacted originals and Peptide Hub has not yet independently tested ARP retail stock.
Price & Value	8 / 20	ARP is not positioned as a low-cost supplier across the broader matched basket. Peptide Hub’s current pricing workbook places its comparative price index at approximately 121.7, indicating pricing materially above the matched market median overall. The 5% PEPTIDEHUB discount improves the customer price.
Community Reputation	4 / 15	The business only began trading in July 2026 and does not yet have the depth of independent customer history available for established Australian vendors. This category is deliberately conservative until more independent feedback accumulates.
Customer Experience	14 / 15	Communication with Peptide Hub has been responsive and transparent. Our first-hand package audit recorded a three-day standard-post delivery from NSW to QLD, with the product securely bubble wrapped inside its branded box and Australia Post padded mailer.
Product Range	6 / 10	A respectable catalogue covering many commonly compared research compounds, with multiple strengths available for several products. It remains smaller than the broadest Australian vendors tracked by Peptide Hub.
Website & Transparency	9 / 10	Clear pricing, stock visibility, accessible laboratory documentation and straightforward product information are positives. ARP has also answered detailed sourcing and testing questions directly.
Total Peptide Hub Score	60 / 100	A professional and transparent start, but stronger independent testing, more competitive pricing and a longer independent reputation are required for a substantially higher rating.

Initial Peptide Hub assessment dated 26 September 2026. Vendor ratings may change as new testing, pricing, package audits and independent customer feedback become available.

Most Important Finding

Australian Research Peptides Testing and COA Transparency

Australian Research Peptides maintains a public laboratory-report library containing Janoshik certificates across part of its catalogue. Making the underlying reports publicly accessible is preferable to simply advertising purity percentages without providing supporting documentation.

However, there is an important distinction in where these certificates come from.

The Janoshik reports were not commissioned by Australian Research Peptides. ARP confirmed directly to Peptide Hub that its current certificates are provided by its upstream supplier/manufacturer. The business does not currently commission its own Janoshik testing and does not hold unredacted originals of the supplier certificates.

During our review, Peptide Hub identified several Janoshik task numbers appearing in the testing libraries of other Australian suppliers. We asked ARP directly about this.

ARP explained that vendors sourcing from the same upstream source may receive the same laboratory documentation for the same batch. This is a plausible explanation for duplicated task numbers, but it also illustrates why supplier-provided testing should not be treated as equivalent to a vendor independently selecting its own Australian retail stock and commissioning testing.

Transparency credit: ARP did not claim that these reports were independently commissioned by the business when questioned. It confirmed that the certificates come from its supplier and said that commissioning testing under the Australian Research Peptides name is something it intends to pursue.

What Do the ARP Janoshik Reports Actually Tell Us?

The reports provide useful evidence about samples tested by Janoshik and supplied through ARP’s upstream supply chain. They are materially more informative than unsupported purity claims.

What they do not currently establish is that Peptide Hub can independently connect every Australian Research Peptides retail vial or batch to the specific sample analysed by the laboratory.

ARP told Peptide Hub that the certificates arrive from its supplier already redacted, meaning the business cannot currently provide Peptide Hub with unredacted originals for private verification.

Peptide Hub view: Supplier/manufacturer COAs are useful supporting evidence, but they should remain clearly distinguished from ARP-commissioned testing and independently purchased retail-sample testing. The strongest next step would be periodic analysis of stock physically held and sold by Australian Research Peptides.

ARP has expressly told Peptide Hub that it is comfortable with us independently purchasing and testing its products.

Does Peptide Hub Independently Verify ARP’s Products?

Not yet.

At the time of this review, Peptide Hub has completed a first-hand package audit of Australian Research Peptides but has not commissioned laboratory analysis of an ARP retail sample.

That means our current assessment of the company’s testing is based on the public supplier-provided Janoshik documentation, ARP’s responses to our questions and the transparency of the information available.

Important distinction: A laboratory report showing identity, purity or measured quantity for one sample does not establish sterility, endotoxin status, safety, regulatory approval or suitability for human use. It also does not automatically establish the composition of every retail vial sold by a vendor.

Price Comparison

Is Australian Research Peptides Expensive?

Australian Research Peptides is generally not one of the cheapest vendors in Peptide Hub’s current matched pricing comparison.

Our current pricing workbook produces a comparative price index of approximately 121.7 for ARP across eligible like-for-like comparisons. An index of 100 represents the matched market median, so the current result places ARP materially above the market median overall.

That does not mean every individual ARP product is expensive. Pricing varies considerably by compound and strength.

Product	ARP List Price	Peptide Hub Price View
BPC-157 10mg	$89.99	Above some of the lower-priced 10mg listings tracked by Peptide Hub.
BPC-157 + TB-500 10mg	$104.99	Reasonable blend pricing, although cheaper alternatives exist.
Melanotan II 10mg	$79.99	Mid-to-upper pricing within the current Australian comparison.
MOTS-C 10mg	$89.99	Reasonable but not positioned at the bottom of the market.
CJC-1295 + Ipamorelin 10mg	$124.99	Mid-market pricing for the combination.
Retatrutide 10mg	$139.99	Competitive against some vendors, but not the cheapest listing tracked.
Retatrutide 20mg	$219.99	Higher upfront price reflecting the larger advertised strength.
Tesamorelin 10mg	$139.99	Reasonable within a generally higher-priced product category.
GHK-Cu 100mg	$139.99	Pricing should be compared on an equivalent strength basis.

Prices checked 26 September 2026 and may change. Peptide Hub compares like-for-like products and strengths wherever possible.

Peptide Hub discount: Code PEPTIDEHUB provides 5% off eligible Australian Research Peptides orders. Standard tracked shipping is currently listed at $12.99, with free shipping on qualifying orders over $199.

Shipping, Checkout and Payment

Australian Research Peptides holds its stock in Australia and has told Peptide Hub that orders are dispatched from Sydney.

Shipping

Stock physically held in Australia
Sydney dispatch
Standard tracked postage available
Express Post available
Standard tracked shipping currently $12.99
Free shipping currently advertised over $199
Three-day NSW to QLD standard delivery observed by Peptide Hub

Payment

PayID
Bank transfer

ARP advised Peptide Hub during the review process that it did not offer card payments. Payment options can change and should be checked at checkout.

Communication has been one of the stronger aspects of our experience with Australian Research Peptides.

The team answered detailed questions about its business history, sourcing arrangements, manufacturer structure and testing documentation. Importantly, it did not attempt to present upstream testing as testing commissioned directly by ARP once we questioned the provenance.

Package audit completed: Peptide Hub’s standard-post order was delivered from New South Wales to Queensland in three days. The product arrived in an Australia Post padded mailer, with the branded product box additionally protected by bubble wrap.

First-Hand Package Audit

Australian Research Peptides Package Audit

Peptide Hub has completed a first-hand packaging audit using an Australian Research Peptides retail order.

What we observed

Dispatch: New South Wales to Queensland.

Delivery: Three days using standard postage.

Packaging: Australia Post padded mailer with the branded product box additionally protected in bubble wrap.

Presentation: Branded outer box and labelled vial arrived intact.

Status: Completed first-hand audit.

View Package Photo →

The package audit records one fulfilment and packaging experience. It does not establish consistent delivery performance, product identity, purity, sterility or suitability for human use.

View All Package Audits →

Community Reputation

Australian Research Peptides Reviews

Community reputation is currently one of the weakest evidence areas for Australian Research Peptides, largely because of how new the business is.

ARP told Peptide Hub that it commenced trading on 12 July 2026 and did not operate under another business structure beforehand.

That gives the business only a short public trading history at the time of this review.

Why the score is conservative: A smooth Peptide Hub order and professional communication are positive signals, but they are not substitutes for a large body of independent customer experiences accumulated over time.

We therefore score this category cautiously rather than assuming that the absence of negative reports means the vendor has an established reputation.

How Established Is Australian Research Peptides?

At this stage, ARP should be viewed as a new entrant rather than an established Australian supplier.

That is not inherently negative. Every vendor begins without a long trading history. What matters is whether delivery performance, communication, testing and customer feedback remain consistent as order volume grows.

Peptide Hub will reassess this part of the score as more independent customer feedback becomes available.

Current position: Early operational signs are positive, but there is not yet enough independent history for Peptide Hub to describe ARP’s reputation as established.

Product Range

Australian Research Peptides has already built a respectable catalogue for a business that only began trading in July 2026.

Our current pricing data includes more than 25 distinct product lines, with additional strengths available for several compounds.

5-Amino-1MQ
BPC-157
BPC-157 + TB-500
Cagrilintide
CJC-1295 no DAC
CJC-1295 + Ipamorelin
DSIP
Epitalon
GHK-Cu
GLOW
Glutathione
Ipamorelin
KLOW

KPV
Melanotan II
MOTS-C
NAD+
PT-141
Retatrutide
Selank
Semax
SS-31
TB-500
Tesamorelin
Tirzepatide

Product Range Score: 6/10. The catalogue covers most of the major compounds commonly compared on Peptide Hub and includes multiple strengths across several products. It remains materially smaller than Australia’s largest research catalogues.

Website and Transparency

Transparency is one of the stronger parts of Australian Research Peptides.

Prices are publicly displayed rather than hidden behind enquiries, stock availability is visible and laboratory reports are accessible through a dedicated COA section.

Public product pricing
Australian stock information
Public laboratory report library
Individual product pages
Stock availability displayed
Shipping information
Contact information
Clear research-use positioning
Mobile-friendly website

The business has also been transparent with Peptide Hub privately.

When asked where its Janoshik reports came from, ARP confirmed that they are supplied upstream rather than commissioned directly by Australian Research Peptides. It also confirmed that it uses one primary Chinese supplier/manufacturer and does not currently possess unredacted versions of those reports.

Why this matters: Transparency does not mean having perfect evidence. Being clear about the limitations of the evidence that exists is itself an important part of a credible testing program.

The main opportunity for improvement is turning that transparency into stronger first-party evidence by commissioning independent testing of ARP’s Australian-held retail inventory.

Pros and Cons

What We Like

Stock physically held and dispatched within Australia
Public supplier-provided Janoshik documentation
Clear disclosure to Peptide Hub about where the COAs come from
Completed package audit with three-day standard NSW to QLD delivery
Secure bubble-wrapped branded presentation
Public pricing and visible stock information
Respectable and growing product range
Responsive communication during our review process
Open to Peptide Hub independently testing retail stock

What Needs Improvement

No ARP-commissioned independent testing program yet
Current Janoshik reports are supplied upstream rather than commissioned by ARP
ARP does not currently hold unredacted originals of the supplier reports
Peptide Hub has not yet independently laboratory-tested an ARP retail sample
Very short trading history since July 2026
Limited independent community reputation so far
Pricing is above the matched market median overall
Payment flexibility is more limited than vendors offering card and digital-wallet checkout

Final Assessment

Our Australian Research Peptides Verdict

Australian Research Peptides has made a solid start, particularly in transparency and communication.

We like that the company publishes its supplier laboratory reports openly and, more importantly, was straightforward when Peptide Hub questioned where those reports came from. ARP has not attempted to represent the current certificates to us as tests commissioned independently by the Australian business.

Our first-hand package audit was also positive. Standard postage from NSW to QLD took three days and the product arrived securely protected in a branded presentation box.

The reason the initial rating remains at 60/100 is evidence depth rather than any major operational failure. Australian Research Peptides is only a few months old, has not yet established a substantial independent community history and does not currently commission its own laboratory testing. Its overall matched pricing is also relatively high compared with the wider market tracked by Peptide Hub.

The clearest route to a higher score is straightforward: commission independent testing of Australian-held stock, build a longer customer history and continue demonstrating consistent fulfilment. If those things happen, this is a vendor with room to move materially higher in the rankings.

Peptide Hub Rating: 60/100

Australian Research Peptides receives an initial Peptide Hub score of 60/100 based on the evidence available as at 26 September 2026. Use code PEPTIDEHUB for 5% off eligible orders.

Visit Australian Research Peptides

Frequently Asked Questions

Australian Research Peptides FAQ

Is Australian Research Peptides legitimate?

Australian Research Peptides is an operating Australian research supplier that began trading in July 2026. Peptide Hub has completed a retail package audit, observed domestic NSW dispatch and reviewed the company’s public laboratory documentation. Its longer-term independent reputation is still developing.

Where does Australian Research Peptides ship from?

ARP told Peptide Hub that its stock is physically held in Australia and orders are dispatched from Sydney. Our own package audit also involved domestic NSW to QLD delivery.

Has Peptide Hub completed an Australian Research Peptides package audit?

Yes. Our standard-post order arrived in Queensland from New South Wales in three days. The branded product box was additionally protected with bubble wrap inside an Australia Post padded mailer.

Does Australian Research Peptides use Janoshik?

Australian Research Peptides publishes Janoshik reports supplied by its upstream supplier/manufacturer. ARP has confirmed to Peptide Hub that it did not commission the current reports itself.

Does Australian Research Peptides independently test its products?

Not under its current testing model. ARP told Peptide Hub that its existing certificates are commissioned upstream and provided by its supplier. The company has expressed interest in commissioning testing under its own name in the future.

Has Peptide Hub independently tested Australian Research Peptides?

Not yet. Peptide Hub has completed a package audit but has not yet commissioned laboratory analysis of an ARP retail sample. ARP has told us that it is comfortable with Peptide Hub independently purchasing and testing its products.

Why do some ARP Janoshik reports appear on other vendor websites?

ARP told Peptide Hub that the reports are supplied by its upstream supplier. Where multiple vendors source the same batch through the same supply chain, the same Janoshik task number may therefore appear in more than one vendor’s laboratory library.

Is Australian Research Peptides expensive?

Across Peptide Hub’s current matched pricing comparison, ARP is generally above the market median overall. Individual products vary, so like-for-like product and strength comparisons remain important.

Does Australian Research Peptides have a discount code?

Yes. Code PEPTIDEHUB provides 5% off eligible Australian Research Peptides orders.

What payment methods does Australian Research Peptides accept?

During the review process ARP advised Peptide Hub that PayID and bank transfer were available and that card payments were not currently offered. Payment options may change and should be checked directly at checkout.

How long does Australian Research Peptides delivery take?

Delivery times vary by location and postage method. Peptide Hub’s own standard-post package audit recorded delivery from New South Wales to Queensland in three days.

When did Australian Research Peptides start?

ARP told Peptide Hub that it began trading on 12 July 2026 and did not operate under another business structure beforehand.

Peptide Hub Australia Review Methodology: Vendor scores are based on testing and transparency, price and value, community reputation, customer experience, product range and website transparency. Reviews reflect information available at the time of assessment and may change as new testing, pricing, package audits and customer feedback become available. Supplier-provided laboratory reports are not assumed to be false simply because a vendor did not commission the analysis itself. Scores instead consider the strength of the evidence and how easily that evidence can be connected to retail inventory. Australian Research Peptides confirmed to Peptide Hub that its current Janoshik reports are supplied through its upstream supplier and were not commissioned directly by ARP. Peptide Hub has completed a package audit but has not yet independently laboratory-tested ARP retail stock. Purity and quantity analysis do not establish sterility, safety or suitability for human use. Peptide Hub may earn an affiliate commission from vendor links. Commercial arrangements do not determine editorial scores. All compounds discussed on this page are presented for lawful research purposes only.

Australian Research Peptides Review (2026)